Skip to main content
Novartis Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • 회사소개 
      • 주요 전략 
      • 직원과 기업문화 
      • 다양성과 포용성 
      • 제품정보  
      • 노바티스그룹 경영진 
      • 핵심 사업부문 
      • 연락처 
      한국노바티스
      회사소개
    • 환자와 보호자 
      • 환자와 보호자에 대한 노바티스의 약속 
      • 주요 질병 분야 
      • 제품정보  
      • 부작용 보고 
      환자와 보호자
      환자와 보호자
    • 의료전문가 
      • 메드허브 
      • 제품정보  
      • 부작용 보고 
      • 혁신 
      • 글로벌 정보서비스 
      의료전문가
      의료전문가
    • 혁신 
      • 임상시험 
      • 기술 플랫폼 
      • 데이터와 디지털 
      • 한국노바티스의 혁신 
      • 노바티스의 혁신 
      • 노바티스 생명의학연구소(NIBR) 
      Novartis Innovation
      혁신
    • 환경, 사회 및 가브넌스 
      • 윤리 위험 및 규정준수 
      • 의약품 접근성 
      • 환경지속가능성 
      • 글로벌 헬스 
      • 윤리적 행동양식 
      • 한국노바티스의 사회적 책임 
      환경, 사회 및 가브넌스
      환경, 사회 및 거버넌스
    • 인재채용 
      • 채용 공고 
      • 우리가 일하는 방식 
      • 웰빙 
      • 다양성과 포용성  
      • 수상내역 
      인재채용
      인재채용
    • Coronavirus 
      multiple coronavirus illustration edit image_1
      코로나바이러스감염증-19 (COVID-19) 업데이트
    한국노바티스
    Home
  1. Home
  2. 인재채용
  3. 채용 공고
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Record to Report Sr. Specialist INSURGENTES Mexico Finance Finance Audit & Finance Mar 19, 2026
Tax Operations Manager INSURGENTES Mexico Finance Finance Audit & Finance Mar 18, 2026
Tax Operations Specialist INSURGENTES Mexico Finance Finance Audit & Finance Mar 17, 2026
Statutory Lead INSURGENTES Mexico Finance Finance Audit & Finance Mar 17, 2026
Logistics Planning Specialist (Temporal 8 months) INSURGENTES Mexico Operations Production / Manufacturing Technical Operations Mar 11, 2026
Strategic Access Manager INSURGENTES Mexico International Sales Market Access Mar 11, 2026
Sales Value Associate CDMX INSURGENTES Mexico International Sales Sales Mar 10, 2026
Therapeutic Area Head Oncology INSURGENTES Mexico International General Management Commercial & General Management Mar 09, 2026
MSL Lead Oncology INSURGENTES Mexico International Development Research & Development Mar 09, 2026
HR Business Partner Director (Mexico-based, Supporting US Organization). INSURGENTES Mexico People & Organization Human Resources Human Resources Mar 09, 2026
MSL Lead CRM & Neuroscience INSURGENTES Mexico International Development Research & Development Mar 09, 2026
Threat Hunting Assoc. Dir. DDIT ISC INSURGENTES Mexico Operations Information Technology Technology Transformation Mar 05, 2026
Sales Value Manager, Oncology INSURGENTES Mexico International Marketing Sales Mar 03, 2026
Medical Information Agent INSURGENTES Mexico US Marketing Research & Development Feb 25, 2026
Sales Value Manager - Specialty Care INSURGENTES Mexico International Marketing Sales Feb 23, 2026
Record to Report Sr Specialist INSURGENTES Mexico Finance Finance Audit & Finance Feb 17, 2026
Assoc. Dir. DDIT IES - HPC Infrastructure Sr. Engineer INSURGENTES Mexico Operations Information Technology Technology Transformation Feb 17, 2026
No matching countries found
검색

한국노바티스

Navigate Novartis
  • 회사소개
  • 환자와 보호자
  • 의료전문가
  • 혁신
  • 환경, 사회 및 거버넌스
  • 인재채용
Other Novartis Websites in Korea
  • NovartisPro
  • Novartis Global
  • 한국노바티스 LinkedIn
  • 한국노바티스 YouTube
Footer Bottom
© 2026 Novartis AG
  • 개인정보 처리방침
  • 이용약관
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
이 사이트는 국내 거주자들을 위한 사이트입니다. KR2205234431